ARCHIVES

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

This article is from The Cancer Letter archive.

Vol. 38 No. 02 | January 13, 2012

Download PDF Visit The Full Archive

Related Articles

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

NCI-Approved Clinical Trials

May 26, 2006

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

Contract Awards Sole Source Negotiations

January 13, 1978

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014